Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'

Gut

Volumn 64, Issue 11, 2015, Pages 1671-1672

  Beuers, Ulrich ^a   Gershwin, M Eric ^b   Gish, Robert G ^c   Invernizzi, Pietro ^d   Jones, David E J ^e   Lindor, Keith ^f   Ma, Xiong ^g   Mackay, Ian R ^h   Parés, Albert ⁱ   Tanaka, Atsushi ^j   Vierling, John M ^k   Poupon, Raoul ^l  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f ARIZONA STATE UNIVERSITY   (United States)

^g SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^h MONASH UNIVERSITY   (Australia)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER; URSODEOXYCHOLIC ACID;

CHOLANGITIS; CLINICAL PRACTICE; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HUMAN; ICD-11; INFLAMMATORY INFILTRATE; LIVER TRANSPLANTATION; MEASUREMENT ACCURACY; MEDICAL LITERATURE; MEDICAL SOCIETY; NOMENCLATURE; PRACTICE GUIDELINE; PRIMARY BILIARY CHOLANGITIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SHORT SURVEY; SOCIAL STIGMA; SURVIVAL TIME; SYMPTOM; BILIARY CIRRHOSIS;

CHOLANGITIS; HUMANS; LIVER CIRRHOSIS, BILIARY; TERMINOLOGY AS TOPIC;

EID: 84947602281     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-310593     Document Type: Short Survey

References (21)

1. Addison T, Gull W. On a certain affection of the skin - vitiligoidea a plana, b tuberosa. Guys Hosp Rep 1851;7:265-76.
2. Hanot V. Étude sur une forme de cirrhose hypertrophique du foie [cirrhose hypertrophique avec ictere chronique]. Paris: JBBaillère, 1876.
3. MacMahon HE, Thannhauser SJ. Xanthomatous biliary cirrhosis: a clinical syndrome. Ann Intern Med 1949;30:121-79.
4. Ahrens EH Jr, Payne MA, Kunkel HG, et al. Primary biliary cirrhosis. Medicine 1950;29:299-364.
5. Sherlock S. Primary biliary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology 1959;37:574-86.
6. Rubin E, Schaffner F, Popper H. Primary biliary cirrhosis chronic non-suppurative destructive cholangitis. Am J Pathol 1965;46:387-407.
7. Sherlock S. Diseases of the liver and biliary system. Blackwell Scientific Publications 1968:305.
8. EASL. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237-67.
9. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology 2009;50:291-308.
10. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology 2008;47:737-45.
11. Bianchi I, Carbone M, Lleo A, et al. Genetics and epigenetics of primary biliary cirrhosis. Semin Liver Dis 2014;34:255-64.
12. Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Ann Rev Pathol 2013;8:303-30.
13. Lleo A, Maroni L, Glaser S, et al. Role of cholangiocytes in primary biliary cirrhosis. Semin Liver Dis 2014;34:273-84.
14. Beuers U, Trauner M, Jansen PLM, et al. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol 2015;62:S25-37.
15. Dyson JK, Hirschfield GM, Adams DH, et al. Novel therapeutic targets in primary biliary cirrhosis. Nat Rev Gastroenterol Hepatol 2015;12:147-58.
16. Odin JA, Huebert RC, Casciola-Rosen L, et al. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001;108:223-32.
17. 3 umbrella - a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies. Hepatology 2010;52:1489-96.
18. 3 umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes. Hepatology 2012;55:173-83.
19. 3 anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 2012;56:687-97.
20. Lleo A, Bowlus CL, Yang GX, et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010;52:987-98.
21. Sasaki M, Miyakoshi M, Sato Y, et al. Increased expression of mitochondrial proteins associated with autophagy in biliary epithelial lesions in primary biliary cirrhosis. Liver Int 2013;33:312-20.